These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 31202362)

  • 41. Analysis of DNA methylation patterns in the tumor immune microenvironment of metastatic melanoma.
    Mitra S; Lauss M; Cabrita R; Choi J; Zhang T; Isaksson K; Olsson H; Ingvar C; Carneiro A; Staaf J; Ringnér M; Nielsen K; Brown KM; Jönsson G
    Mol Oncol; 2020 May; 14(5):933-950. PubMed ID: 32147909
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comprehensive analysis of ferritin subunits expression and positive correlations with tumor-associated macrophages and T regulatory cells infiltration in most solid tumors.
    Hu ZW; Chen L; Ma RQ; Wei FQ; Wen YH; Zeng XL; Sun W; Wen WP
    Aging (Albany NY); 2021 Apr; 13(8):11491-11506. PubMed ID: 33864445
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The panoramic picture of pepsinogen gene family with pan-cancer.
    Shen S; Li H; Liu J; Sun L; Yuan Y
    Cancer Med; 2020 Dec; 9(23):9064-9080. PubMed ID: 33067881
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Integrative analysis identifies potential DNA methylation biomarkers for pan-cancer diagnosis and prognosis.
    Ding W; Chen G; Shi T
    Epigenetics; 2019 Jan; 14(1):67-80. PubMed ID: 30696380
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A radiomics approach to assess tumour-infiltrating CD8 cells and response to anti-PD-1 or anti-PD-L1 immunotherapy: an imaging biomarker, retrospective multicohort study.
    Sun R; Limkin EJ; Vakalopoulou M; Dercle L; Champiat S; Han SR; Verlingue L; Brandao D; Lancia A; Ammari S; Hollebecque A; Scoazec JY; Marabelle A; Massard C; Soria JC; Robert C; Paragios N; Deutsch E; Ferté C
    Lancet Oncol; 2018 Sep; 19(9):1180-1191. PubMed ID: 30120041
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Integrative data mining and meta-analysis to investigate the prognostic role of microRNA-200 family in various human malignant neoplasms: A consideration on heterogeneity.
    Yuan L; Bing Z; Yan P; Li R; Wang C; Sun X; Yang J; Shi X; Zhang Y; Yang K
    Gene; 2019 Oct; 716():144025. PubMed ID: 31394177
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comprehensive Analysis of Glutamate-Rich WD Repeat-Containing Protein 1 and Its Potential Clinical Significance for Pancancer.
    Wu Y; Wu X; Li Y; Zhao W; Yue Y; Wu B; Liu J; Chen X; Shen A
    Biomed Res Int; 2021; 2021():8201377. PubMed ID: 34616846
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Seven-CpG-based prognostic signature coupled with gene expression predicts survival of oral squamous cell carcinoma.
    Shen S; Wang G; Shi Q; Zhang R; Zhao Y; Wei Y; Chen F; Christiani DC
    Clin Epigenetics; 2017; 9():88. PubMed ID: 28852427
    [TBL] [Abstract][Full Text] [Related]  

  • 49. DNA methylation loss promotes immune evasion of tumours with high mutation and copy number load.
    Jung H; Kim HS; Kim JY; Sun JM; Ahn JS; Ahn MJ; Park K; Esteller M; Lee SH; Choi JK
    Nat Commun; 2019 Sep; 10(1):4278. PubMed ID: 31537801
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clustered protocadherins methylation alterations in cancer.
    Vega-Benedetti AF; Loi E; Moi L; Blois S; Fadda A; Antonelli M; Arcella A; Badiali M; Giangaspero F; Morra I; Columbano A; Restivo A; Zorcolo L; Gismondi V; Varesco L; Bellomo SE; Giordano S; Canale M; Casadei-Gardini A; Faloppi L; Puzzoni M; Scartozzi M; Ziranu P; Cabras G; Cocco P; Ennas MG; Satta G; Zucca M; Canzio D; Zavattari P
    Clin Epigenetics; 2019 Jul; 11(1):100. PubMed ID: 31288858
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Diagnostic and prognostic biomarkers of common urological cancers based on aberrant DNA methylation.
    Peng D; Ge G; Xu Z; Ma Q; Shi Y; Zhou Y; Gong Y; Xiong G; Zhang C; He S; He Z; Li X; Ci W; Zhou L
    Epigenomics; 2018 Sep; 10(9):1189-1199. PubMed ID: 30182734
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Identifying prognostic biomarkers based on aberrant DNA methylation in kidney renal clear cell carcinoma.
    Chen G; Wang Y; Wang L; Xu W
    Oncotarget; 2017 Jan; 8(3):5268-5280. PubMed ID: 28029655
    [TBL] [Abstract][Full Text] [Related]  

  • 53. EGFR DNA Methylation Correlates With EGFR Expression, Immune Cell Infiltration, and Overall Survival in Lung Adenocarcinoma.
    Xu Z; Qin F; Yuan L; Wei J; Sun Y; Qin J; Deng K; Zheng T; Li S
    Front Oncol; 2021; 11():691915. PubMed ID: 34447695
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The Genomic Impact of DNA CpG Methylation on Gene Expression; Relationships in Prostate Cancer.
    Long MD; Smiraglia DJ; Campbell MJ
    Biomolecules; 2017 Feb; 7(1):. PubMed ID: 28216563
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Analysis of immunobiologic markers in primary and recurrent glioblastoma.
    Rahman M; Kresak J; Yang C; Huang J; Hiser W; Kubilis P; Mitchell D
    J Neurooncol; 2018 Apr; 137(2):249-257. PubMed ID: 29302887
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Carbonic Anhydrase 4 serves as a Clinicopathological Biomarker for Outcomes and Immune Infiltration in Renal Cell Carcinoma, Lower Grade Glioma, Lung Adenocarcinoma and Uveal Melanoma.
    Xu Y; Xu WH; Shi SN; Yang XL; Ren YR; Zhuang XY; Qu YY; Zhang HL; Zhang XF
    J Cancer; 2020; 11(20):6101-6113. PubMed ID: 32922550
    [No Abstract]   [Full Text] [Related]  

  • 57. DNA methylation signatures for 2016 WHO classification subtypes of diffuse gliomas.
    Paul Y; Mondal B; Patil V; Somasundaram K
    Clin Epigenetics; 2017; 9():32. PubMed ID: 28392842
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Identification of diagnostic markers in colorectal cancer via integrative epigenomics and genomics data.
    Kok-Sin T; Mokhtar NM; Ali Hassan NZ; Sagap I; Mohamed Rose I; Harun R; Jamal R
    Oncol Rep; 2015 Jul; 34(1):22-32. PubMed ID: 25997610
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Early Epigenetic Markers for Precision Medicine.
    Dumitrescu RG
    Methods Mol Biol; 2018; 1856():3-17. PubMed ID: 30178243
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Individualized analysis reveals CpG sites with methylation aberrations in almost all lung adenocarcinoma tissues.
    Yan H; Guan Q; He J; Lin Y; Zhang J; Li H; Liu H; Gu Y; Guo Z; He F
    J Transl Med; 2017 Feb; 15(1):26. PubMed ID: 28178989
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.